4.4 Article

Interlaboratory Gleason grading variation affects treatment: a Dutch historic cohort study in 30 509 patients with prostate cancer

Related references

Note: Only part of the references are listed.
Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Article Oncology

Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in The Netherlands

Rachel N. Flach et al.

Summary: Significant variation in prostate cancer grading was observed between and within Dutch pathology laboratories, which may impact treatment strategies and prognosis assessment of prostate cancer patients. Case-mix correction did not explain the variation, highlighting the need for better standardization of prostate cancer grading.

CANCERS (2021)

Article Urology & Nephrology

Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study

Barbara Lily Therese Rijksen et al.

Summary: The study found that less than one-third of intermediate-risk PCa patients treated with EBRT receive ADT in the Netherlands, with significant variation in prescription between institutions. In high-risk patients, the majority received recommended ADT, but there is room for improvement in guideline adherence.

EUROPEAN UROLOGY FOCUS (2021)

Article Pathology

The effect of an e-learning module on grading variation of (pre)malignant breast lesions

Carmen van Dooijeweert et al.

MODERN PATHOLOGY (2020)

Article Urology & Nephrology

Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational study

B. W. H. van Santvoort et al.

SCANDINAVIAN JOURNAL OF UROLOGY (2020)

Article Medicine, General & Internal

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

J. L. Donovan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Urology & Nephrology

Interobserver variability in Gleason histological grading of prostate cancer

Tayyar A. Ozkan et al.

SCANDINAVIAN JOURNAL OF UROLOGY (2016)

Article Medicine, General & Internal

Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

M. Minhaj Siddiqui et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Urology & Nephrology

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system

Phillip M. Pierorazio et al.

BJU INTERNATIONAL (2013)